Asset

Treprostinil sodium

Liquidia Corporation Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 213005NDALIQUIDIA TECHNOLOGIES INC

Marketed products (4)

  • YUTREPIA
  • YUTREPIA
  • YUTREPIA
  • YUTREPIA